News
Swisscom Expands Trust in Verimatrix VCAS with Full Migration to the Cloud
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Swisscom, a longstanding Verimatrix
Transgene Announces Financial Calendar for 2023
Regulatory News:
TRANSGENE (Paris: TNG) today announced its financial reporting dates for 2023:
March 16, 2023:
2022 Fiscal Year Results
May 10, 2023:
First
Pharnext strengthens its Senior Leadership Team with the appointment of Scott Johnson as VP, Head of Quality
Poxel Announces its Financial Calendar for 2023
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Blue Spark Technologies to Highlight Continuous Patient Temperature Monitoring at CES 2023
Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, will showcase TempTraq® at the 2023 Consumer Electronics Show (CES) at the Las Vegas Convention Center
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sensorion Announces First Patient Enrolled in Phase 2a Proof of Concept Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity
Regulatory News:
Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
GEVELOT S.A.: Weekly report of share buyback December 29, 2022
Pharnext strengthens its ties with Néovacs to secure the next steps in its development
Ipsen receives Complete Response Letter for palovarotene, an investigational treatment for fibrodysplasia ossificans progressiva
Regulatory News:
The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the New Drug Application for palovarotene, an investigational treatment for the
Poxel Announces Drawdown of the Remaining Two Tranches of its Equity-linked Financing Facility and Provides Corporate Update
POXEL SA (Euronext: POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Eutelsat Statement on the Suspension of Broadcasting Activities With Respect to Certain Channels in Russia and Iran
Regulatory News:
Eutelsat Communications (Euronext Paris: ETL) implements as soon as possible all restrictive measures on broadcasting activities adopted by the competent French and European
Median Technologies: Financial Communications Schedule for the First Half of 2023
Regulatory News:
Median Technologies (ALMDT:PA) (Paris:ALMDT), announces the publication date for its 2022 results:
Publication
Date
2022 results
April 20, 2023*
EQS-News: Abivax receives FDA agreement on pediatric development plan with obefazimod in IBD
Dassault Systèmes, McPhy and Visiativ Team Up to Drive the Green Energy Transition
Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) (Paris:DSY), McPhy Energy (Euronext Paris: FR0011742329, MCPHY.PA ) and Visiativ (Euronext Growth Paris: FR0004029478, ALVIV) are
Kaufman & Broad SA: SIGNING OF THE CONTRACTS FOR THE A7/A8 – GARE AUSTERLITZ TRANSACTION
Gecina Achieves the Maximum CDP Rating and Confirms Its Leadership in Several ESG Rankings
Regulatory News:
Gecina (Paris:GFC) has been recognized for its climate change performance and transparency leadership by the Climate Change Carbon Disclosure Project (CDP)
Gecina has also made
Teleperformance Scores Highest Rating as a Leader in Everest Group’s Healthcare CX Management Assessment in North America in 2022
Regulatory News:
Teleperformance (Paris:TEP), the global leader in outsourced customer and citizen experience management and related digital services, reached the summit with the highest rating
Transgene Announces Upcoming Investor Meetings
Regulatory News:
TRANSGENE (Paris:TNG) today announces that Management will participate in several investor events in January and February 2023, as set out below.
Transgene will meet
Carbios veröffentlicht ersten Nachhaltigkeitsbericht und unterstreicht sein Engagement für Kreislaufwirtschaft und Umweltverantwortung
Pflichtmitteilung:
Carbios (Euronext Growth Paris: ALCRB) (Paris:ALCRB), ein Pionier in der Entwicklung und Industrialisierung biologischer Technologien zur Neugestaltung des Lebenszyklus von
Carbios Publishes First Sustainability Report and Underscores Commitment to Circularity and Environmental Responsibilities
Regulatory News:
Carbios (Euronext Growth Paris: ALCRB) (Paris:ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastics and
Valbiotis gibt Unterzeichnung einer Forschungspartnerschaft zur intestinalen Mikrobiota mit der MEDIS-Einheit der Universität Clermont Auvergne bekannt
Pflichtmitteilung:
Valbiotis (FR0013254851 – ALVAL, PEA-SME-qualifiziertes Unternehmen), ein Forschungs- und Entwicklungsunternehmen mit Schwerpunkt auf wissenschaftlicher Innovation zur
Valbiotis Announces the Signature of a Research Partnership in Intestinal Microbiota With the MEDIS Unit From the Clermont Auvergne University
Regulatory News:
Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible), a Research and Development company committed to scientific innovation for preventing and combating metabolic and
EQS-News: Abivax to attend the J.P. Morgan 41st Annual Healthcare Conference
Teleperformance Certified as Great Place to Work® in the Entire Latin American Region For 2022
Regulatory News:
Teleperformance (Paris:TEP), the global leader in outsourced customer and citizen experience management and related digital services, announced that its Latin American operations